Literature DB >> 14500935

The cortical ischemic core and not the consistently present penumbra is a determinant of clinical outcome in acute middle cerebral artery occlusion.

Tudor G Jovin1, Howard Yonas, James M Gebel, Emanuel Kanal, Yue Fang Chang, Stephen Z Grahovac, Steven Goldstein, Lawrence R Wechsler.   

Abstract

BACKGROUND AND
PURPOSE: Patient selection for acute stroke therapy based on physiology rather than on time may lead to expansion of the therapeutic window, improved outcomes, and fewer side effects than currently achieved. This approach requires early determination of both irreversible (core) and reversible (penumbra) ischemia in acute stroke.
METHODS: Using established perfusion thresholds, we characterized the relationship among core, penumbra, and brain tissue perfused above penumbral thresholds (non-core/non-penumbra [NC/NP]) in 36 patients with middle cerebral artery (MCA) stem occlusion who underwent quantitative cerebral blood flow (CBF) assessment with xenon-enhanced CT within 6 hours of symptom onset.
RESULTS: While great variability in the mean+/-SD percentage of core (37.6+/-18.7) and NC/NP (30.3+/-16.6) was observed, the percentage of penumbra was relatively constant from individual to individual, constituting approximately one third of the cortical MCA territory (32.1+/-7). In univariable and multivariable analyses, percent core and not percent penumbra was significantly associated with outcome.
CONCLUSIONS: In acute MCA occlusion, penumbra is consistently present within a relatively narrow range, despite great variability in the size of core. This may explain why the core and not the penumbra is the main determinant of outcome in our group of patients. Recanalization therapy in acute MCA occlusion should ideally be guided by diagnostic methods capable of rapidly and reliably identifying irreversible ischemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500935     DOI: 10.1161/01.STR.0000091232.81947.C9

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  34 in total

Review 1.  Neuroimaging of ischemia and infarction.

Authors:  Erica C Sá de Camargo; Walter J Koroshetz
Journal:  NeuroRx       Date:  2005-04

2.  Impact of stroke co-morbidities on cortical collateral flow following ischaemic stroke.

Authors:  Ifechukwude J Biose; Deborah Dewar; I Mhairi Macrae; Christopher McCabe
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-24       Impact factor: 6.200

3.  Changing directions in acute stroke diagnostics : good-bye "mismatch"?

Authors:  Rüdiger von Kummer
Journal:  Klin Neuroradiol       Date:  2009-06

4.  Poor clinical outcome despite successful arterial recanalization. What went wrong? How can we do better?

Authors:  Mayank Goyal
Journal:  Neuroradiology       Date:  2010-02-12       Impact factor: 2.804

Review 5.  Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?

Authors:  Jeannette N Stankowski; Rishi Gupta
Journal:  Antioxid Redox Signal       Date:  2010-10-25       Impact factor: 8.401

6.  Regional cerebral blood flow levels as measured by xenon-CT in vascular territorial low-density areas after subarachnoid hemorrhage are not always ischemic.

Authors:  E Fainardi; M F Tagliaferri; C Compagnone; A Tanfani; F Cocciolo; R Battaglia; M Frattarelli; R Pascarella; L Targa; A Chieregato
Journal:  Neuroradiology       Date:  2006-06-28       Impact factor: 2.804

7.  Clinical use of computed tomographic perfusion for the diagnosis and prediction of lesion growth in acute ischemic stroke.

Authors:  Branko N Huisa; William P Neil; Ronald Schrader; Marcel Maya; Benedict Pereira; Nhu T Bruce; Patrick D Lyden
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-12-14       Impact factor: 2.136

8.  Imaging Biomarkers for Intra-arterial Stroke Therapy.

Authors:  Olvert A Berkhemer; Shervin Kamalian; R Gilberto González; Charles B L M Majoie; Albert J Yoo
Journal:  Cardiovasc Eng Technol       Date:  2013-12-01       Impact factor: 2.495

9.  Predictors of functional outcome vary by the hemisphere of involvement in major ischemic stroke treated with intra-arterial therapy: a retrospective cohort study.

Authors:  Albert J Yoo; Javier Romero; Reza Hakimelahi; Raul G Nogueira; James D Rabinov; Johnny C Pryor; R Gilberto González; Joshua A Hirsch; Pamela W Schaefer
Journal:  BMC Neurol       Date:  2010-04-23       Impact factor: 2.474

10.  MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization.

Authors:  Albert J Yoo; Luis A Verduzco; Pamela W Schaefer; Joshua A Hirsch; James D Rabinov; R Gilberto González
Journal:  Stroke       Date:  2009-04-09       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.